Journal
NATURE REVIEWS CANCER
Volume 11, Issue 4, Pages 254-267Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3023
Keywords
-
Categories
Funding
- German Research Foundation
- German Cancer Research Foundation
- National Cancer Centre, Heidelberg/Mannheim
Ask authors/readers for more resources
Can an abundantly expressed molecule be a reliable marker for the cancer-initiating cells (CICs; also known as cancer stem cells), which constitute the minority of cells within the mass of a tumour? CD44 has been implicated as a CIC marker in several malignancies of haematopoietic and epithelial origin. Is this a fortuitous coincidence owing to the widespread expression of the molecule or is CD44 expression advantageous as it fulfils some of the special properties that are displayed by CICs, such as self-renewal, niche preparation, epithelial-mesenchymal transition and resistance to apoptosis?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available